Archive for Friday, July 24, 2009

KU to announce Tuesday new clinical trial in Wichita

July 24, 2009


Kansas University Cancer Center leaders on Tuesday plan to announce the opening of a clinical trial of Nanotax, a cancer treatment drug, in the Wichita area.

Nanotax was developed through KU Cancer Center, Lawrence-based CritiTech and researchers on the Lawrence campus. The first Phase 1 human testing of the drug began in Kansas City last year.

Nanotax is a reformulation of a commonly used chemotherapy drug, Paclitaxel, into nanoparticles that allow it to be water-soluble. The reformulation reduces a number of unwanted side effects.

Officials from the Kansas Bioscience Authority and Cancer Centers of Kansas also are scheduled to be at Tuesday’s press conference, which will be at 9:30 a.m. at KU School of Medicine’s Wichita campus in the Sunflower Room.


Use the comment form below to begin a discussion about this content.

Commenting has been disabled for this item.